Quipt Home Medical Corp (QIPT)

Over the past six months, Quipt Home Medical Corp. completed the acquisition of Hart Medical on September 3, 2025, which was expected to add $60 million in revenue. In August 2025, Quipt confirmed receipt of an undervalued offer from Forager, which the Board denounced. On December 15, 2025, Quipt entered into a definitive agreement for its acquisition by affiliates of Kingswood Capital Management and Forager Capital Management. Quipt reported its fourth quarter and fiscal year 2025 financial results on December 15, 2025, and shares gained +34.1% the next day. On March 24, 2025, Quipt announced its strategic priorities for calendar year 2025, focusing on enhancing shareholder value. The share price as of January 7, 2026, was $3.57, showing a 15.53% increase since January 8, 2025, and reached a new 52-week high of $3.58 on January 7, 2026.

Quipt Home Medical Corp. experiences demand seasonality related to patient deductible resets, resulting in modestly lower resupply volumes during the first half of the second fiscal quarter of 2025. However, Quipt observed improved momentum in volume exiting both March and April 2025. An analysis of QIPT's stock performance suggests a seasonal pattern, but this does not directly translate to product demand seasonality.

Quipt Home Medical Corp. is a U.S.-based provider of durable medical equipment (DME) and home medical equipment (HME), specializing in end-to-end respiratory care and chronic disease management for patients at home. The company operates within the Healthcare sector, specifically in the Medical Distribution industry, renting and selling essential medical equipment and supplies, and generating a significant portion of its revenue through recurring resupply orders. Major products and services include respiratory solutions, sleep apnea and PAP treatment, daily and ambulatory aids, power mobility, chronic disease management, and automated resupply programs.

Quipt Home Medical Corp. has a significant operational presence across the United States, with its operational headquarters in Wilder, Kentucky. The company operates in over 26 states and has approximately 115 locations with over 1,000 employees. Quipt has a solid presence in the Southwest and Midwest regions and is actively pursuing strategic acquisitions to expand its footprint and market penetration nationally. As of September 2023, the company had 125 locations across 26 U.S. states, serving 287,500 active patients and working with 34,400 referring physicians.

Quipt Home Medical Corp.'s brand reputation appears to be characterized by strategic growth and efforts to enhance shareholder value, despite some market challenges. The completion of the Hart Medical acquisition and the announcement of strategic priorities reflect positively on the company's growth strategy. The consistent high percentage of recurring revenue indicates a stable business model. The existence of multiple acquisition proposals suggests external recognition of the company's value. Revenue headwinds and cybersecurity risks could have a minor impact on reputation, but the company's overall strategic direction seems to mitigate broader negative perception.

Quipt Home Medical Corp.'s ownership structure includes a blend of institutional and retail investors, with a significant stake held by company insiders. As of September 30, 2025, Quipt had 112 to 113 institutional owners holding approximately 24.2 to 24.4 million shares, representing about 42.85% to 77.88% of the stock. Forager Capital Management, LLC, CLARET ASSET MANAGEMENT Corp, and Vanguard Group Inc are the largest institutional owners. Company insiders hold a substantial portion, with CEO Gregory John Crawford owning over 4 million shares, representing 9.22% of the company. Overall, insiders hold about 13.40% to 15.48% of the stock, and retail investors hold approximately 36.94%.